SE9902936D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
SE9902936D0
SE9902936D0 SE9902936A SE9902936A SE9902936D0 SE 9902936 D0 SE9902936 D0 SE 9902936D0 SE 9902936 A SE9902936 A SE 9902936A SE 9902936 A SE9902936 A SE 9902936A SE 9902936 D0 SE9902936 D0 SE 9902936D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
active ingredient
propylsulphonyl
phenylethoxy
benzothiazol
Prior art date
Application number
SE9902936A
Other languages
Swedish (sv)
Inventor
John Dixon
Philip Holt
Francis Ince
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9902936A priority Critical patent/SE9902936D0/en
Publication of SE9902936D0 publication Critical patent/SE9902936D0/en
Priority to PCT/GB2000/003112 priority patent/WO2001012191A2/en
Priority to AU64601/00A priority patent/AU6460100A/en
Priority to ARP000104310A priority patent/AR025340A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a pharmaceutical composition, pharmaceutical product or kit comprising a first active ingredient (A) being 4-hydroxy-7-[2-[2-[3-[2-phenylethoxy]propylsulphonyl]ethylamino]ethyl]-1,3-benzothiazol-2(3<i>H</i>-one or a pharmaceutically acceptable salt thereof, and a second active ingredient (B) being a glucocorticoid, for use in the treatment of obstructive airways diseases.
SE9902936A 1999-08-18 1999-08-18 Pharmaceutical compositions SE9902936D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9902936A SE9902936D0 (en) 1999-08-18 1999-08-18 Pharmaceutical compositions
PCT/GB2000/003112 WO2001012191A2 (en) 1999-08-18 2000-08-14 Pharmaceutical compositions comprising a 7-(2-aminoethyl)-benzothiazolone and a glucocorticoid
AU64601/00A AU6460100A (en) 1999-08-18 2000-08-14 Pharmaceutical compositions
ARP000104310A AR025340A1 (en) 1999-08-18 2000-08-18 PHARMACEUTICAL COMPOSITIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902936A SE9902936D0 (en) 1999-08-18 1999-08-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE9902936D0 true SE9902936D0 (en) 1999-08-18

Family

ID=20416694

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9902936A SE9902936D0 (en) 1999-08-18 1999-08-18 Pharmaceutical compositions

Country Status (4)

Country Link
AR (1) AR025340A1 (en)
AU (1) AU6460100A (en)
SE (1) SE9902936D0 (en)
WO (1) WO2001012191A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004021959D1 (en) 2003-11-21 2009-08-20 Theravance Inc COMPOUNDS OF AGONISTIC EFFECT ON THE BETA2 ADRENEER RECEPTOR AND THE MUSCARIN RECIPE
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
UY31905A (en) 2008-06-18 2010-01-29 Astrazeneca Ab DERIVATIVES OF BENZOXAZINONA, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds

Also Published As

Publication number Publication date
WO2001012191A3 (en) 2001-09-07
AR025340A1 (en) 2002-11-20
WO2001012191A2 (en) 2001-02-22
AU6460100A (en) 2001-03-13

Similar Documents

Publication Publication Date Title
MXPA04000920A (en) Aminoisoxazole derivatives active as kinase inhibitors.
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
CA2381097A1 (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
DE60228857D1 (en) AMINO PHTALAZINONE DERIVATIVES, USE AS KINASE INHIBITORS, PREPARATION AND PHARMACEUTICAL COMPOSITION
CA2098302A1 (en) Medicaments
CA2392879A1 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders
WO2001062737A3 (en) Amino pyrazole derivatives useful for the treatment of obesity and other disorders
NO20034612L (en) 3,4-di-substituted cyclobutene-1,2-dione, pharmaceutical compositions comprising the compounds, and use of the compounds for the manufacture of medicaments for the treatment of chemokine-mediated diseases
WO2001098290A3 (en) Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
BR0210122A (en) Compound or a pharmaceutically acceptable salt thereof, method for treating or preventing a disease, use of the compound or salt thereof, and method for preparing the same
HUP0203312A3 (en) Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use
BR0108435A (en) Formulation and use of low dose entecavir
EE04997B1 (en) Pharmaceutical composition containing loteprednol and antihistamines, a medicament containing these agents, a process for the preparation of the medicament and use of a combination of these agents
HUP0104410A2 (en) A composition for the prevention and/or treatment of atherosclerosis
ATE233754T1 (en) DIPHENYL-PIPERIDINE DERIVATIVES
SE9902935D0 (en) Pharmaceutical compositions
SE9902937D0 (en) Pharmaceutical compositions
SE9902936D0 (en) Pharmaceutical compositions
DE60202590D1 (en) 2H-1-BENZOPYRANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
HUP9802897A2 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
SE9903995D0 (en) New combination
AU5879798A (en) Agents inhibiting progress of pterygium and postoperative recurrence of the same
SE9902938D0 (en) Pharmaceutical compositions
SE0001916D0 (en) Novel formulation
IT1291340B1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND USE OF COLOSTRUM FOR THE TREATMENT OF ORAL CAVITY DISEASES